Wellinks

Wellinks is a cardiopulmonary care platform provider. From its funding announcement.

$10M Series BRaised 2 months agoNew Haven, USAHealthcare & MedtechUSA
Visit website →

In their own words

What Wellinks says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "cardiopulmonary care platform provider". Source

Product

Public signal Read from the company's own description of what the funding supports.

Why now

Where Wellinks is today

Wellinks announced a Series B round of $10M on 5 August 2026, led by Interim CEO and Chief Operating Officer Jennifer Barretta.

Latest round
Series B
Amount
$10M
Announced
5 August 2026
Headquarters
New Haven, USA
Sector
Healthcare & Medtech
Investors
Interim CEO and Chief Operating Officer Jennifer Barretta
Also participating
Not stated
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

58
Steady growth
1 funding signal in the last 90 days
Funding recency
28/40
announced within the last 90 days
Round scale
12/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 5 August 2026
    $10M Series B
    Led by Interim CEO and Chief Operating Officer Jennifer Barretta.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Product launches and new tiers
  • Product leadership hiring
  • Commercial scale-up
  • New market preparation

Opportunities this could create

  • Provider partnerships
  • Product leadership
  • Design partners
  • Specialist engineering
  • Clinical evidence

Based on the Healthcare & Medtech sector, a Series B round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals
  • 5 August 2026$10M Series B announced
  • 5 August 2026Stated priority: product

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Wellinks is open to

Not yet specified

Wellinks has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Wellinks

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Wellinks?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector